Literature DB >> 10423472

Fever and neutropenia--how to use a new treatment strategy.

R W Finberg, J A Talcott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10423472     DOI： 10.1056/NEJM199907293410509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Management of febrile neutropenia in low risk cancer patients.

Authors:  B A Oppenheim; H Anderson
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.

Authors:  James A Talcott; Beow Y Yeap; Jack A Clark; Robert D Siegel; Elizabeth Trice Loggers; Charles Lu; Paul A Godley
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

3.  Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.

Authors:  Ann M Hendricks; Elizabeth Trice Loggers; James A Talcott
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

4.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

5.  Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.

Authors:  Edwin Pun Hui; Linda K S Leung; Terence C W Poon; Frankie Mo; Vicky T C Chan; Ada T W Ma; Annette Poon; Eugenie K Hui; So-Shan Mak; Maria Lai; Kenny I K Lei; Brigette B Y Ma; Tony S K Mok; Winnie Yeo; Benny C Y Zee; Anthony T C Chan
Journal:  Support Care Cancer       Date:  2010-09-04       Impact factor: 3.603

Review 6.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections.

Authors:  Alexander A Navarini; Karl S Lang; Admar Verschoor; Mike Recher; Annelies S Zinkernagel; Victor Nizet; Bernhard Odermatt; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

8.  Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.

Authors:  Maria Hatzistilianou; Aleka Rekliti; Fanni Athanassiadou; Dorothea Catriu
Journal:  Inflamm Res       Date:  2009-10-06       Impact factor: 4.575

9.  Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial.

Authors:  Weidong Lu; Ursula A Matulonis; Anne Doherty-Gilman; Hang Lee; Elizabeth Dean-Clower; Andrew Rosulek; Carolyn Gibson; Annekathryn Goodman; Roger B Davis; Julie E Buring; Peter M Wayne; David S Rosenthal; Richard T Penson
Journal:  J Altern Complement Med       Date:  2009-07       Impact factor: 2.579
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.